A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity

• Published in: Transplantation proceedings Vol. 33; no. 3; pp. 2355 - 2359
• Main Authors: Marchal-Bras-Goncalves, R, Rouas-Freiss, N, Connan, F, Choppin, J, Dausset, J, Carosella, E.D, Kirszenbaum, M, Guillet, J.-G
• Format: Journal Article Conference Proceeding
• Language: English
• Published: New York, NY Elsevier Inc 01.05.2001; Elsevier Science
• Subjects: Biological and medical sciences; Cells, Cultured; Clone Cells; Cloning, Molecular; Cytotoxicity, Immunologic - drug effects; Cytotoxicity, Immunologic - physiology; Escherichia coli; Fundamental and applied biological sciences. Psychology; Fundamental immunology; Histocompatibility Antigens Class I - immunology; Histocompatibility Antigens Class I - pharmacology; HLA Antigens - immunology; HLA Antigens - pharmacology; HLA-G Antigens; Humans; K562 Cells; Killer Cells, Natural - drug effects; Killer Cells, Natural - immunology; Polymerase Chain Reaction; Recombinant Fusion Proteins - isolation & purification; Recombinant Fusion Proteins - pharmacology; Tissue, organ and graft immunology; Human; HLA-System; Immune response; Major histocompatibility system; Cytotoxicity; Soluble form; In vitro; Biological activity; Natural killer cell; Immunomodulator; Established cell line; Recombinant protein; Class I histocompatibility antigen